 |
|
What's New
|
Amex: ANX 0.149 +0.009
|
June 15, 2009
ADVENTRX Pharmaceuticals Announces Closing of Financing
June 8, 2009
ADVENTRX Pharmaceuticals Announces Financing
June 2, 2009
ADVENTRX Receives Notice From NYSE Amex
May 12, 2009
ADVENTRX Pharmaceuticals Reports First Quarter 2009 Financial Results
May 7, 2009
ADVENTRX Announces Results From ANX-514 Bioequivalence Study
March 25, 2009
ADVENTRX Grants Exclusive Rights to ANX-514 in South Korea
March 25, 2009
ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results
March 20, 2009
ADVENTRX Announces Further Cost-Cutting Measures
February 10, 2009
ADVENTRX Provides Update on Strategic Transaction Process
February 5, 2009
Adventrx Completes Patient Enrollment in ANX-514 Bioequivalence Study
January 5, 2009
ADVENTRX Announces Further Cost-Cutting Measures
December 15, 2008
ADVENTRX Exploring Strategic Options
November 06, 2008
ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update
November 04, 2008
ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Global Healthcare Conference
October 30, 2008
ADVENTRX Pharmaceuticals to Report Third Quarter 2008 Results
October 20, 2008
ADVENTRX Announces Restructuring and Cost Reduction Initiatives
|
